ArticleAnnals of translational medicine2022

Safety and efficacy of hetrombopag in patients with chronic immune thrombocytopenia: a single-arm, open-label, multi-center phase 1 study.

Heng Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.